Literature DB >> 7091244

A comparison of morphine and methadone disposition in the maternal-fetal unit.

H H Szeto, J G Umans, J McFarland.   

Abstract

The extent of fetal exposure to a drug is a function of placental and fetal clearances of the drug. We have compared the placental and fetal clearances of morphine and methadone under steady-state conditions in the chronic pregnant ewe preparation. Morphine and methadone were infused at constant rates to the mother and fetus, and steady-state maternal and fetal plasma concentrations of the drugs were determined by radioimmunoassay. At steady state after maternal infusion of the drugs, the maternal: fetal free drug concentration ratios were 7.6 +/- 0.6 for morphine and 2.9 +/- 0.6 for methadone. The clearance of morphine from mother to fetus (24.9 +/- 3.0 ml/min) was fifteenfold less than that of methadone (390.3 +/- 92.8 ml/min). Fetal nonplacental clearance of methadone (381 +/- 89.1 ml/min) was higher than that of morphine (125.6 +/- 15.3 ml/min). Fetal clearance accounted for 67.4 +/- 3.9% of total morphine clearance from the fetal compartment, but only 42.8 +/- 4.9% of total methadone clearance. Fetal clearance of methadone increases with age in the early third trimester. The lower extent of fetal exposure to morphine compared to methadone is due primarily to a slower clearance of morphine across the placenta from mother to fetus rather than a more rapid clearance of morphine by the fetus.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7091244     DOI: 10.1016/0002-9378(82)90118-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

1.  Placental transfer and fetal elimination of morphine-3-beta-glucuronide in the pregnant baboon.

Authors:  Marianne Garland; Kirsten M Abildskov; Tung-Wah Kiu; Salha S Daniel; Piper Weldy; Raymond I Stark
Journal:  Drug Metab Dispos       Date:  2008-06-19       Impact factor: 3.922

2.  A novel pharmacokinetic method for analysis of placental transfer of latamoxef in humans.

Authors:  T Yamamoto; J Yasuda; M Kanao; H Okada; T Oguma; H Yamada
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

Review 3.  Models for placental transfer studies of drugs.

Authors:  P Bourget; C Roulot; H Fernandez
Journal:  Clin Pharmacokinet       Date:  1995-02       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.